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Abstract
The study has analysed the action of histamine in the rabbit venous system and evaluated its potential role in contraction during
increased venous pressure. We have found that a great variety exists in histamine sensitivity and H1-histamine receptor expression in
various types of rabbit veins. Veins of the extremities (saphenous vein, femoral vein, axillary vein) and abdomen (common iliac vein,
inferior vena cava) responded to histamine by a prominent, concentration-dependent force generation, whereas great thoracic veins
(subclavian vein, superior vena cavas, intrathoracic part of inferior vena cava) and a pelvic vein (external iliac vein) exhibited slight
sensitivity to exogenous histamine. The lack of reactivity to histamine was not due to increased activity of nitric oxide synthase (NOS) or
heme oxygenase-1. H1-histamine receptor expression of veins correlated well with the histamine-induced contractions. Voltage-depend-
ent calcium channels mediated mainly the histamine-induced force generation of saphenous vein, whereas it did not act in the inferior
vena cava. In contrast, the receptor-operated channels were not involved in this response in either vein. Tyrosine phosphorylation
occurred markedly in response to histamine in the saphenous vein, but not in the inferior vena cava. Histamine induced a prominent 
kinase activation in both vessels. Protein kinase C and mitogen-activated protein kinase (MAPK) were not implicated in the histamine-
induced intracellular calcium sensitization. Importantly, transient clamping of the femoral vein in animals caused a short-term
constriction, which was inhibited by H1-histamine receptor antagonist in vivo. Furthermore, a significantly greater histamine
immunopositivity was detected in veins after stretching compared to the resting state. We conclude that histamine receptor density
adapts to the actual requirements of the circulation, and histamine liberated by the venous wall during increased venous pressure
contributes to the contraction of vessels, providing a force for the venous return.
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Introduction
Research of cardiovascular regulation is a well-established area of
physiological science. However, the role of veins in this process
has never received much emphasis, although about 70% of the 
circulating blood volume is distributed in the venous system 
[1–2]. The main driving force of venous return to the heart was
based on the venous pump mechanism. This comprises muscle
pumps in extremities, thoraco-abdominal pump vis a fronte and 
vis a tergo mechanisms of the heart and myogenic mechanism 
of veins [3–7].
It is known that veins are sensitive to a variety of neurotrans-
mitters and autacoids and these can be produced in the wall of 
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the veins [2, 7]. Veins have been described as eliciting contrac-
tile responses to norepinephrine [2, 8–12], epinephrine [13–18],
angiotensin II [17–24] and endothelin [25–28]. In addition,
purinergic mediators such as ATP are also capable of inducing
significant venoconstrictions [29, 30]. However, to the best of
our knowledge, there are no convincing experimental data for 
the role of these substances – with the exception of adrenergic
neurotransmitters – in the involvement of physiology and 
pathophysiology of venous return [2, 31]. Vasoactivity of 
histamine is also well known, and it is described that this auta-
coid has a prominent action not only in arteries, but in veins as
well [32–40].
The aim of our study was to analyse the overall mechanical
activity of histamine in the rabbit venous system and to evaluate
whether histamine has a potential role in venous contraction 
during increased venous pressure. We have found that a great
variety exists in the histamine sensitivity and H1-histamine receptor
expression in various types of rabbit veins, and that histamine
receptor density adapts to the actual and local requirements of
the circulation. On the basis of our results, it can be supposed
that histamine liberated by the venous wall during increased
venous pressure can play a significant role in the mechanism of
venous return.
Materials and methods
Animals
Male New Zeeland (Lab-Nyul Kft, Godollo, Hungary) white rabbits were
used in the study (weight: 3.2–3.8 kg). The experimental protocol has been
approved by the Animal Care and Use Committee of University of
Debrecen. Animals were kept in metal cages at room temperature and 
12 hr light cycle. Animals had access to standard granulated food with the
addition of fresh vegetables.
Contractility measurements
Animals were killed by a single bonus injection of sodium pentobarbital 
(60 mg/kg) into a marginal ear vein. Various veins were dissected by
microscopic control and excess connective tissue excised. Vascular spec-
imens were cut into rings approximately 4 mm long. Special care was
taken to avoid contact with the luminal surface of the rings in order to pre-
serve the endothelium. The endothelium was removed in some rings,
where the luminal surface of vessels was rubbed for 10–20 sec. with a
wooden stick to damage the endothelium. Rings were vertically mounted
on two stainless steel triangular clips, the lower clip being attached to a
moveable support, and the upper clip to a force displacement transducer
in a 10-ml organ bath containing Krebs solution (37C), the composition of
which was (mmol/l): NaCl, 118; KCl, 4.7; CaCl2, 2.5; NaH2PO4, 1.0; MgCl2,
1.2; NaHCO3, 24.9 and glucose 11.5 with pH 7.4 when gassed with 
95% O2 and 5% CO2 (pH 7.4). Tension of vascular strips was measured
isometrically by transducer (SG-01D, Experimetria, Budapest, Hungary),
and the output fed to a potentiometric recorder (SP-K2V, Riken Denshi,
Tokyo, Japan). Specimens were given an initial tension of 10 mN 
and allowed to stabilize this tension for at least 2 hrs. Following the 
equilibration period, preparations were exposed to 10 M histamine
(Sigma, St. Louis, MO, USA) to reach a steady level of tension. Integrity or
removal of endothelium was monitored functionally by the quality of
responses to acetylcholine (0.1–10 M, Sigma). Following a 30-min.
wash-out period, a cumulative concentration-response (E/[A]) curve was
constructed to histamine (1 nM to 100 M). At the completion of the
experiments, tissues were lightly blotted, measured and weighed. The
cross-sectional area of each preparation was calculated using the follow-
ing formula: cross-sectional area (mm2)  weight (mg)/(length (mm) 
density (mg/mm3)). The density of the vessels was assumed to be 
1.05 mg/mm3. Responses to histamine were then calculated as the
increase in tension (mN) in response to each concentration of
agonist/cross-sectional area of tissue (mm2).
Western blotting
Tissue samples were collected in lysis buffer [20 mM Tris-HCl, pH 7.4, 5 mM
ethylene glycol tetraacetic acid (EGTA), 1 mM 4-(2-aminoethyl) benzensul-
fonyl fluoride, protease inhibitor cocktail diluted 1:100, all from Sigma] and
the protein content of samples was measured by a BCA protein assay
(Pierce, Rockford, IL, USA) [41–43]. The samples were subjected to SDS-
PAGE (7.5% gels were loaded with 30 g protein per lane), transferred to
BioBond nitrocellulose membranes (Whatman, Maidstone, England). After
the membranes were blocked with 5% non-fat milk in phosphate-buffered
saline for 1 hr, the blots were probed with anti-Histamine or anti-H1-hista-
mine receptor rabbit primary antibodies (1:200, Santa Cruz). Horseradish
peroxidase-polymer-conjugated, goat anti-rabbit antibodies (1:1000,
BioRad) were used as the secondary antibody and the immunoreactive
bands were visualized by SuperSignal® West Pico Chemiluminescent
Substrate-enhanced chemiluminescence (Pierce). Immunoblots were then
subjected to densitometric analysis using an Intelligent Dark Box (Fuji,
Tokyo, Japan) and the Image Pro Plus 4.5.0 software (Media Cybernetics,
Silver Spring, MD, USA). To assess equal loading, membranes were stripped
in 200 ml of 50 mM TRIS-HCl buffer (pH 7.5) containing 2% SDS and 0.1%-
mercaptoethanol (all from Sigma) at 65C for 1 hr and were re-probed with
a rabbit cytochrome-C (CytC) antibody (Santa Cruz) followed by a similar
visualization procedure as described above.
Immunohistochemistry
According to the slight modification of the original method described in
Anichtchik et al. [44] and Rinne et al. [45] after excision, the samples of
veins were immediately immersed in the fixative, 4% l-ethyl-3.3 (dimethy-
laminopropyl) carbodiimide (EDAC, Sigma) in 0.1M phosphate buffer, pH
7.0 for 2 days followed by fixation in 4% paraformaldehyde (Sigma),
embedded in paraffin and processed for immunohistochemistry. The
expression of histamine was determined by horseradish-peroxidase (HRP)
based method using diaminobenzidine (DAB) as a chromogene. In brief,
paraffin-embedded sections (5 m), after antigen retrieval [with 1 mg/ml
protease (Sigma Aldrich, St. Louis, MO, USA) diluted in TRIS-HCl], endoge-
nous peroxidase activity was blocked with peroxidase blocking solution
(DAKO, Glostrup, Denmark) (10 min., RT). Non-specific binding was pre-
vented by incubating the sections with Protein Block Serum Free Reagent
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(DAKO, 5 min., RT). The tissue sections were then incubated overnight at
4C with the primary anti-Histamine H1-receptor antibody (1:50, Santa
Cruz, Biotechnology, Santa Cruz, CA, USA). Sections were then incubated
with a rabbit anti-goat HRP-polymer-conjugated secondary antibody
(1:1000, BioRad). Immunoreactions were finally visualized using DAB-sub-
strate Histamine H1-receptor antibody (1:50, Santa Cruz, Biotechnology,
Santa Cruz, CA, USA). Sections were then incubated with a rabbit anti-goat
HRP-polymer-conjugated secondary antibody (1:1000, BioRad).
Immunoreactions were finally visualized using DAB-substrate  (EnVision
kit, DAKO) and the sections were counterstained by haematoxylin (Sigma-
Aldrich) and mounted in aqueous mounting medium (DAKO).
In addition, for negative controls of the labelling procedure, primary 
antibodies were omitted from the procedure. Immunohistochemical 
images were captured and digitalized using an RT Spot Colour CCD camera
(Diagnostic Instruments, Inc., Sterling Heights, MI, USA) integrated on a Nikon
Eclipse 600 fluorescence and light microscope (Nikon, Tokyo, Japan). Analysis
of images was carried out using Image Pro Plus 4.5 software. Identification of
immunpositive pixels was based on specific colour of immunostaining. A mask
was applied for immunpositive pixels and the number of positive pixels was
counted in the region of the given endothelium section. Data are presented as
percentage of immunpositive pixels in the selected region.
Ultrasonic echo-tracking
The experiments were performed in 12 New Zeeland rabbits weighing
3.2–3.8 kg, anesthetized with sodium pentobarbital 30 mg/kg i.v. into the
marginal ear vein. The animals were placed on a heated table to maintain
constant body temperature (39.0  0.4 C). A 1 cm segment of right
femoral vein was prepared just below the Poupart’s ligament and a tourni-
quet was placed gently around the vessel. After preparation of the vessel,
a non-invasive ultrasound probe was positioned in the distal portion of
femoral vein for measuring its internal diameter by an ultrasonic echo-
tracking device (ATL HDI 5000) C8-5 transducer with 5–8 MHz probe scan
frequency. Using a Doppler mode, the probe was positioned by the charac-
teristic sound of the femoral vein and its focal zone was close to the cen-
tre of the vein. Signals of the venous walls were tagged by an electronic
tracker, allowing the continuous measurement of the venous diameter.
After measuring the resting internal diameter of femoral vein, a 15-sec.
occlusion was applied, followed by release of the vessel clamp. One group
of animals (n 6) was treated by i.v. administration of 4 mg/kg pyrilamine
(a H1-histamine receptor blocker; Sigma) before clamping. In the other
group of animals (controls, n  5), phosphate-buffered saline (PBS) was
administered as a solvent.
Data analysis
Agonist-induced changes in mechanical activity were expressed as the per-
centage reduction of pre-drug contractile force. Individual E/[A] curve data
were fitted by means of a least-square iterative computer program to a
logistic function of the following form: E  Emax[A]nH/[A]nH[EC50]nH,
where E denotes the effect, Emax is the asymptote, [A] is the concentration
of the agonist, EC50 is the concentration producing a half-maximal
response and nH is the midpoint slope parameter.
The data are expressed as means  S.E.M. The EC50 values were
expressed as their negative base 10 logarithms (pD2 values) throughout
the text. Multiple comparisons between the experimental groups were per-
formed by one-way ANOVA with a Newman–Keuls post hoc test. Statistical
significance was evaluated by Student’s t-test, where appropriate; P 	
0.05 was taken as the level of significance.
Results
Regional variability of histamine-induced 
contractions
Histamine (10 pM to 100 M) evoked a concentration-dependent
increase of contractile force, but Emax of E/[A] was significantly
different in various types of veins. Veins have substantial hista-
mine sensitivity in the lower (saphenous vein, femoral vein) and
upper extremities (axillary vein), as well as in the abdomen (com-
mon iliac vein, inferior vena cava). In contrast, the thoracic veins
(thoracic part of inferior vena cava, right and left superior vena
cavas, subclavian vein) and one pelvic vein, external iliac vein were
virtually insensitive to histamine (Figs 1–3 and Table 1).
Fig. 1 Histamine-induced contraction in isolated rabbit vessels. Saphenous
vein (open circle) (n  12), femoral vein (full circle) (n  7), external iliac
vein (open square) (n 9). The histamine-induced increases in tension are
normalized for vessel cross-sectional area, and absolute values of the
increase in tension are shown. Data represent mean  S.E.M.
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Role of nitric oxide or CO liberation 
in the histamine resistance
To analyse the action of a possibly increased nitric oxide or carbon
monoxide release in the reduced histamine-induced contraction of
special veins, after constructing the first concentration-response
curve and a washout period, external iliac veins (n  5) and right
superior vena cavas (n  6) were exposed to 100 M NG-nitro-L-
arginine (L-NOARG) to block NOS activity. After the blocking of NOS
enzymes, no significant differences were observed in histamine-
induced responses of both veins. Similar results were detected if the
above specimens were incubated by the inhibitor of heme oxyge-
nase-1 Zn-protoporphyrine IX (ZnPP) of 20 M (data not shown).
Immunoblotting of H1-histamine receptor proteins
H1-histamine receptors were expressed in high density in saphe-
nous vein and inferior vena cava, whereas expression level of
these receptors was low in internal iliac vein and right and left
superior vena cavas (Fig. 4).
Differences in signalling mechanism 
of histamine-sensitive veins
In these experiments, the signalling of two high histamine-
sensitive veins (saphenous vein, inferior vena cava) was 
compared. The possible role of membrane calcium channels
(voltage-dependent calcium channels [VOC] and receptor-
operated channels [ROC]), intracellular calcium stores and
enzymes involved in calcium sensitization (-kinase, tyrosine
kinase, MAPK, protein kinase C) were studied. In saphenous
vein, experiments with nifedipine and SKF-96365 demon-
strated that histamine activates mainly VOC, whereas the role
of ROC is negligible. In the inferior vena cava, the roles of both
types of calcium channels are minor in mechanical activity
induced by histamine (Fig. 5).
Fig. 2 Histamine-induced contraction in isolated rabbit vessels. Abdominal
part (open circle) of inferior vena cava (n  10), common iliac vein (full
circle) (n  5), intrathoracic part (open square) of inferior vena cava (n 
7). The histamine-induced increases in tension are normalized for vessel
cross-sectional area, and absolute values of the increase in tension are
shown. Data represent mean  S.E.M.
Fig. 3 Histamine-induced contraction in isolated rabbit vessels. Axillary
vein (open circle) (n  5), right superior vena cava (full circle) (n  7),
subclavian vein (open square) (n  5). The histamine-induced increases
in tension are normalized for vessel cross-sectional area, and absolute
values of the increase in tension are shown. Data represent mean 
S.E.M.
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For investigating the role of the possible implication of Ca2
sensitization pathways, we studied the action of various protein
kinases previously known to be involved in Ca2 sensitization
process. Thus the effects of inhibitors of  kinase, protein kinase
C, MAPK and tyrosine kinase were investigated.  kinase inhibitors
(50 M HA-1077 or Y-27632 10 M) all virtually completely inhib-
ited the histamine-induced force generation in both saphenous
vein and inferior vena cava ring preparations (Figs 6–7). Tyrosine
phosphorylation was studied by application of genistein 50 M.
Strong difference was observed between the two types of vessels
in the genistein-induced inhibition of histamine contraction. In
saphenous veins, genistein induced a 43% inhibition, whereas it
was practically ineffective in inferior vena cava indicating the
diverse implication of tyrosine phosphorylation in histamine’s
actions in the above vessels. The inhibition of protein kinase C by
calphostin 0.2 M or inhibition of MAPK by PD-098059 10 M
did not influence significantly the development of force in both
saphenous veins and the inferior vena cava (data not shown).
Effects of transient clamping/release 
on the femoral vein in vivo
In anesthetized rabbits, the femoral vein just below the Poupart’s
ligand was clamped for 20 sec., followed by a release. In
controls, after clamping, an immediate slight constriction was
monitored by an echo-tracking device. This constriction became
more prominent after releasing the clamping, then returned to
the pre-clamping value. In another group of animals, 4 mg/kg
pyrilamine, a specific H1-histamine receptor blocker was injected
into the marginal ear vein. This induced an initial dilation of the
femoral vein, which then returned to the control value. When
clamping, the femoral vein was not constricted, but dilated and
this venodilation became pronounced after the release of the
clamp (Fig. 8).
Effect of stretch of femoral vein 
on the histamine distribution and content
Rabbits were anesthetized and saphenous vein and inferior vena
cava were prepared. One part of the proximal region of these veins
was cut and immersed in 4% EDAC, embedded in paraffin and
processed for immunohistochemistry (non-stretched veins). A sil-
icon catheter was inserted into the proximal end of the veins and
PBS was injected into the vein by a 80–100 mmHg controlled
pressure for 20 sec. After this procedure, the intact part of vein
was excised and used for immunohistochemistry following the
above protocol (stretched veins). Histamine staining was more
intensive on stretched saphenous vein and inferior vena cava than
on corresponding controls suggesting a causative relationship
between stretching and histamine release (Fig. 9).
Table 1 Effect of histamine on contractility parameters in isolated ring preparations of various rabbit veins
Vein n pD2 Emax P (Emax)
1 Inferior vena cava (abdominal part) 10 6.11  0.10 17.8  1.1
2 Saphenous vein 12 5.73  0.04 16.2  0.4
>0.05 
1 versus 2
3 Axillary vein 5 6.07  0.12 14.7  0.3
>0.05
2 versus 3
4 Femoral vein 7 6.03  0.08 10.7  0.8
<0.05
3 versus 4
5 Common iliac vein 5 6.29  0.11 9.5  0.6
>0.05
4 versus 5
6 Inferior vena cava (thoracic part) 7 5.57  0.06 1.5  0.1
<0.01
5 versus 6
7 Right superior vena cava 7 5.77  0.16 0.6  0.1
<0.05
6 versus 7
8 Subclavian vein 5 5.10  2.60 0.5  0.7
>0.05
7 versus 8
9 External iliac vein 9 5.74  0.07 0.3  0.01
>0.05
8 versus 9
Data are mean values  S.E.M.
Analysis of statistical significance was performed with variance analysis (ANOVA) with the Newman–Keuls post-hoc test.
n: number of experiments; pD2: negative base 10 logarithms of EC50 values; Emax: maximum effect (mN/mm2); P: statistical significance.
J. Cell. Mol. Med. Vol 15, No 12, 2011
2619© 2011 The Authors
Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Study of histamine liberation from mast cells
In isolated saphenous veins, experiments were carried out to
study the possible cellular basis of histamine release. The mast
cell activator compound, 48/80, at a concentration of 300 M,
was not able to induce contraction both in endothelium intact and
denuded saphenous vein rings (data not shown).
Discussion
The major findings of this study are the followings: (i) Histamine
sensitivity of rabbit veins shows an extreme variability. Veins of
the extremities (saphenous vein, femoral vein, axillary vein) and
abdominal veins (common iliac vein, inferior vena cava) respond
to histamine by a prominent, concentration-dependent force
generation, whereas great thoracic veins (subclavian vein, supe-
rior vena cavas, intrathoracic parts of the inferior vena cava) and
a pelvic vein (external iliac vein) displayed minimum sensitivity
to exogenous histamine. The concentration-response curve for
histamine (ii) was not influenced by mechanical deprivation of
endothelial layer. The low histamine sensitivity (iii) of selected
veins (external iliac vein, superior vena cava) was not changed
by the inhibition of NOS or heme oxigenase-1 enzyme by 
L-NOARG or Zn protoporphyrine-IX, respectively. H1-histamine
receptor expression (iv) of the selected high and low histamine-
sensitivity veins correlated well with the histamine-induced force
generation and (v) there are some differences in excitation-
contraction coupling between the histamine-reactive vessels
saphenous vein and inferior vena cava. Although VOC play a sig-
nificant role in the histamine-induced force generation of saphe-
nous vein, they do not in the inferior vena cava. The role of ROC
is very slight in both types of veins. Tyrosine phosphorylation is
profoundly involved in the saphenous vein, but not in the inferior
vena cava. Histamine induces a prominent  kinase activation in
both vessels. Protein kinase C and MAPK are not implicated in
the histamine-induced intracellular calcium sensitization in any
of the vessels studied. In vivo experiments (vi) of transient
clamping of the femoral vein caused a short-term constriction
followed by a moderate dilation. Following the blockade of 
H1-histamine receptors, no constriction was demonstrated and
(vii) in veins with great sensitivity to histamine (saphenous vein,
inferior vena cava) a significantly greater histamine immunopos-
itivity was detected after stretching than in resting state. As a
pharmacological approach, it seems (viii) that after stretched
conditions, histamine release probably is not originated from
Fig. 4 H1 histamine receptor expression in various rabbit veins. (A)
Specific H1 immunopositive bands at ~55 kD of a representative
immunoblot and corresponding CytC staining. (B) Optical density of H1
immunopositive bands, normalized to CytC. n 
 3 in each group.
Fig. 5 Role of voltage-operated (nifedipine treatment) and receptor oper-
ated (SKF-96365 treatment) channels in the histamine-induced contraction
of rabbit saphenous vein (grid columns; n  both 6) and abdominal part
of inferior vena cava (hatched columns; n  both 5). Contractile force is
expressed in % of control. ***P 	 0.001.
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mast cells, but the origin of its release from endothelial or 
non-mast cells cannot be excluded.
It is an important question in the physiology and pathophysiol-
ogy whether active vasoconstriction plays an important role in
venous return and raising of end-diastolic volume. It is generally
accepted that in orthostasis, the increase of myogenic tone and an
increment of sympathetic tone have a great significance in the
regulation of venous blood flow [2, 6, 7, 46]. To the best of our
knowledge, our present paper is the first to describe the potential
role of histamine as an autacoid in the active vasoconstriction of
veins, emphasizing the involvement of histamine in the venous
return. We have shown that by increasing the venous pressure by
clamping of the proximal part of the saphenous vein, a possible
histamine-induced transient vasoconstriction develops. Histamine
liberation from the vessel wall was convincingly documented by
immunohistology, where after stretching of saphenous vein and
inferior vena cava a strong increase in histamine immunoreactiv-
ity can be detected. The overall results of the present study
emphasize that the venous network is extremely plastic at the
point of view of histamine-induced regulation. In the proximal
parts of the body, in extremities, but also in the abdomen, the his-
tamine receptor expression and the maximum contractile
response to histamine are very high, whereas in the thorax
(because of the changes of intrathoracic pressure) the veins are
virtually insensitive to histamine. Regional variabilities for the sen-
sitivity of rabbit veins were described earlier by Tsuru et al. [39],
but these authors did not detect such practically inactive veins, as
our present study did. This variability is physiologically quite log-
ical, because the thoraco-abdominal venous pump is effectively
Fig. 6 Effects of inhibition of  kinase by 50 M HA-1077 (n  both 5) 
or 5 M Y-27632 (n  both 4) on the histamine-induced contraction in
rabbit saphenous vein (grid columns) and abdominal part of inferior vena
cava (hatched columns). Contractile force is expressed in % of control.
***P 	 0.001.
Fig. 7 Original record of the action of  kinase inhibition (50 M H-1077)
on the histamine-induced force generation in rabbit saphenous vein.
Fig. 8 Typical clamping/release studies in anesthetized rabbit under control
condition and after administration of 4 mg/kg i.v. pyrilamine.
J. Cell. Mol. Med. Vol 15, No 12, 2011
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operating and no additional venoconstriction is needed for venous
return in this region. It is not completely understood that the
insensitivity of the external iliac vein operates in the pelvic part. It
might ensure a reservoir or buffer function preventing the simul-
taneous constriction of all veins in the lower extremities and the
abdomen, providing as a ‘fountain pump’ and making the venous
return continuous. It is mentioned that in this region of the body,
the plasticity of the histamine sensitivity is noteworthy. In some
experiments, we observed arteriolization of the external iliac vein
when forming a side-to-side anastomosis between the femoral
vein and artery, the external iliac vein became highly sensitive to
histamine. In addition, we have observed that under certain phys-
iological and pathological circumstances (post-partum period,
intrapelvic tumours), a clear-cut shift can be observed from the
external iliac vein toward common iliac vein, i.e. the external iliac
vein responds well to histamine, but the common iliac artery lost
its histamine sensitivity (Galajda and Szentmiklósi: unpublished
data). This phenomenon can be high significant, mainly in women
during pregnancy.
Histamine is an endogenous substance that is widely distrib-
uted in various tissues and has been involved in a variety of
physiological and pathophysiological processes. This autacoid is
implicated in the initial phase of an anaphylactic reaction and
acts on various smooth muscles including vascular. The biolog-
ical action of histamine operates by three different surface
receptors, i.e. H1-, H2- and H3-receptors. We have analysed only
the role of H1-histamine receptors, as H2 and H3 antagonists
have very slight or negligible action on the H1-histamine recep-
tor-induced contractions ([39, 47], Galajda and Szentmiklosi:
unpublished data). In our experiments, regional differences in
H1-histamine receptor expression and signalling mechanism
were also shown. Histamine-induced contractions and H1-hista-
mine receptor expressions are well correlated in sensitive and
non-sensitive veins. As far as the regional variability of signalling
mechanism is concerned, the role of the activation of voltage-
operated calcium channels is significant in histamine-induced
saphenous vein contraction, but not in inferior vena cava. A spe-
cial emphasis was placed on the analysis of histamine-related
intracellular calcium sensitizing mechanisms. In vessels, a vari-
ety of protein kinases are implicated in Ca2 sensitization mech-
anisms:  kinase, protein kinase C, mitogen-activated protein
kinase and tyrosine phosphorylation [48–51]. In our study, tyro-
sine phosphorylation had a significant role in the Ca2 sensitiza-
tion mechanism underlying the histamine-induced contractions
of saphenous vein, but no involvement was detected in inferior
vena cava. Activation of  kinase was strongly implicated in the
histamine-induced Ca2 sensitization in both veins. In our
experiments, endothelium did not play any role in the histamine-
induced contraction. In histamine-insensitive veins, the slight
reactivity of the specimens can be due mainly to low H1-hista-
mine receptor density, and no role of a possible increased liber-
ation of nitric oxide or CO was supposed. However, we did not
investigate the potential role of peroxynitrate as an oxidative and
nitrosative stressor, but we cannot rule out its possible contribu-
tion to histamine-induced venorelaxation [52].
In histochemical studies, we convincingly demonstrated that
stretching of the veins induces a remarkable histamine release in
the vascular tissue. The source of histamine is possibly not the
vascular mast cells, but in this case liberation of non-mast cell
histamine [53] could be suggested. In vivo experiments by induc-
ing venoconstriction during clamping of the femoral vein, and the
fact that this process could be reversed by pyrilamine, a selective
Fig. 9 Histamine immunostaining in
stretched and non-stretched veins of rab-
bit. Histamine was visualized using DAB
chromogen (brown). Immunopositive
pixels were selected and counted on
images using Image Pro Plus 4.5 soft-
ware. NC: negative control.
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H1-histamine receptor blocker, confirmed our theory that
depending on where the vein wall is stressed, this induces hista-
mine liberation followed by a venoconstriction. This process
might be a ‘helper’ in addition to the musculovenous pump and
the myogenic tone.
It should be emphasized that these results could also be
observed in human veins obtained from multidonors and the
variability of the histamine sensitivity, histamine receptor expres-
sion and excitation-contraction coupling of various veins are also
operating (Galajda and Szentmiklósi: unpublished results).
Furthermore, detailed studies are needed to clarify the physiolog-
ical and pathophysiological significance of these results, but on
the basis of our study it can be suggested that histamine release
after stretching the vein wall may play a significant role in the
regulation of venous circulation and widen the implication of this
autacoid in a variety of physiological processes.
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